31 results
424B5
IFRX
InflaRx N.V.
28 Jun 24
Prospectus supplement for primary offering
4:56pm
Gift or inheritance taxes will arise in the Netherlands with respect to a transfer of our ordinary shares by way of a gift by, or on the death … of, a holder of our ordinary shares who is resident or deemed resident of the Netherlands at the time of the gift or such holder’s death.
Non-residents
6-K
EX-99.1
IFRX
InflaRx N.V.
24 Jun 24
Current report (foreign)
4:16pm
and SARS-CoV-2, that leads to high rates of death among hospitalized patients. ARDS is believed to be driven by the body´s immune response
6-K
EX-99.3
IFRX
InflaRx N.V.
1 Nov 23
Current report (foreign)
8:04am
(Arm A) and in combination with pembrolizumab (Arm B) - in patients with programmed cell death protein 1 (PD-1) or programmed cell death ligand 1 (PDL-1
6-K
EX-99.3
IFRX
InflaRx N.V.
10 Aug 23
Report of Foreign Private Issuer
8:00am
) - in patients with programmed cell death protein 1 (PD1) or programmed cell death ligand 1 (PDL1) inhibitor resistant/refractory, locally advanced
6-K
EX-99.3
yaw20yzotomcr72lz9
11 May 23
Current report (foreign)
8:00am
6-K
EX-1.1
h9y2mz95
13 Apr 23
Current report (foreign)
4:01pm
424B5
0b35uigi5
13 Apr 23
Prospectus supplement for primary offering
8:48am
424B5
knph slait
11 Apr 23
Prospectus supplement for primary offering
4:11pm
6-K
EX-99.2
tmi6 nb1gjpw5qx71
9 Nov 22
Current report (foreign)
7:52am
6-K
EX-99.4
fae70y5eti qx
9 Nov 22
Current report (foreign)
7:52am
6-K
EX-99.3
21irc0
9 Nov 22
Current report (foreign)
7:52am
6-K
EX-99.3
31jd jht8
5 Aug 22
Current report (foreign)
6:07am
6-K
EX-99.2
xi2bal
5 Aug 22
Current report (foreign)
6:07am
6-K
EX-99.1
9iyyc8u
15 Nov 21
Current report (foreign)
7:36am
6-K
EX-99.1
c3s1a8dmct
1 Mar 21
Current report (foreign)
12:00am
424B5
fdqmn
26 Feb 21
Prospectus supplement for primary offering
5:10pm